Hikma Pharmaceutical | HIK - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
argenx SE USD 417M 62M 2026-06
AstraZeneca USD 5.8B 735M 2026-06
Autolus Therapeutics Ltd USD 39.95M 4.16M 2026-03
Bayer EUR 3.7B 356M 2026-03
Fresenius EUR 819M 143M 2025-12
Genmab DKK 208M 60M 2025-12
GlaxoSmithKline GBP 2.19B 75M 2026-06
GRIFOLS EUR 281M 5.7M 2026-03
Hikma Pharmaceutical USD 288M 149M 2025-12
Lakefront Biotherapeutics EUR 35.5M 8.91M 2026-03
Merck EUR 1.52B 80M 2026-03
Orion EUR 98.9M 7M 2026-06
Recordati EUR 192.76M 5.52M 2026-03
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.33B 419M 2026-03
UCB EUR 1.47B 193M 2025-12